Gene Polymorphism Association Studies in Dialysis: Vascular Access
Authors:
- Matthias GirndtMGMatthias Girndt
- Gunnar H. HeineGHGunnar H. Heine
- Christof UlrichCUChristof Ulrich
- for the DialGene ConsortiumFCfor the DialGene Consortium
- 22 January 2007
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 20 (1) , 63-67
Abstract
Complications of the vascular access site for hemodialysis are a major cause of morbidity, suboptimal dialysis, and hospitalization. Vascular access for dialysis that is achieved by central venous catheters is associated with complications such as infection and thrombosis. Arteriovenous fistulas and grafts are also at risk for infectious complications. Further, proliferation of the venous wall with secondary thrombosis is a common pathophysiological process that leads to vascular access dysfunction. Genetic polymorphisms that contribute to vascular access failure are found among factors of the coagulation cascade, and host mediators that induce endothelial dysfunction as well as vessel wall proliferation. The two most common mutations of coagulation factors seem to influence the risk of central venous catheter and fistula thrombosis. Indeed, both the single nucleotide polymorphism of the factor V gene at amino acid position 506 (factor V Leiden mutation) and the prothrombin 20210 polymorphism have been associated with thrombotic complications of the vascular access. Among the endothelium-directed factors, a polymorphism of the methylene tetrahydrofolate reductase gene coding for an enzyme that degrades the endothelium toxic product homocysteine, has been associated with fistula failure. While the angiotensin converting enzyme polymorphism does not seem to be associated with vascular access complications, polymorphisms of the profibrogenic cytokine transforming growth factor-beta1 are associated with the prognosis of native arteriovenous fistulae. The role of pro- and anti-inflammatory cytokine gene polymorphisms as prognostic factors for vascular access is yet to be clearly defined.Keywords
This publication has 30 references indexed in Scilit:
- Genetics in Dialysis: Gene Polymorphism Association Studies in Dialysis: Anemia and Host ImmunitySeminars in Dialysis, 2006
- Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 StudyKidney International, 2005
- Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studiesAmerican Heart Journal, 2003
- Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel TherapiesBlood Purification, 2003
- Role of genetic mutations in vascular access thrombosis among hemodialysis patients waiting for renal transplantationTransplantation Proceedings, 2002
- Vascular access use in Europe and the United States: Results from the DOPPSKidney International, 2002
- Heterozygosity for factor V Leiden in a hameodialysis patient with recurrent shunt thrombosisNephrology Dialysis Transplantation, 1997
- Homocysteine and Risk of Premature Coronary Heart DiseaseCirculation, 1996
- Resistance to activated protein C (APC): mutation at ARG506 of coagulation factor V and vascular access thrombosis in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Hemodialysis vascular access morbidity in the United StatesKidney International, 1993